Dr Kate Eggleston

2024

Journal - Research Article

Tennant, M., Frampton, C., Mulder, R., Eggleston, K., & Beaglehole, B. (2024). Changes in sodium valproate dispensing in women of childbearing age with a diagnosis of borderline personality disorder in Aotearoa New Zealand. New Zealand Medical Journal/Te ara tika o te hauora hapori, 137(1597), 36-42. Retrieved from https://www.nzmj.org.nz/

Journal - Research Other

Hitchon, E. G. D., Eggleston, K., Mulder, R. T., Porter, R. J., & Douglas, K. M. (2024). The Aotearoa New Zealand doctor shortage: Current context and strategies for retention. New Zealand Medical Journal/Te ara tika o te hauora hapori, 137(1592), 9-13. Retrieved from https://www.nzmj.org.nz/

Northwood, K., Eggleston, K., Every-Palmer, S., Galbally, M., Warren, N., Berk, M., … Suetani, S. (2024). The state of academic psychiatry in Aotearoa New Zealand and Australia: Data from a survey of the Royal Australian and New Zealand College of Psychiatrists membership. Australian & New Zealand Journal of Psychiatry. Advance online publication. doi: 10.1177/00048674241240592

Conference Contribution - Published proceedings: Abstract

Eggleston, K. (2024). Current status of academic psychiatry in Australia and New Zealand and contrast to international trends. Australian & New Zealand Journal of Psychiatry, 58(Suppl. 1), (pp. 54). doi: 10.1177/00048674241241938

Gill, N., Eggleston, K., Harvey, S., & Siskind, D. (2024). Benchmarking models of academic psychiatry in Australia and New Zealand. Australian & New Zealand Journal of Psychiatry, 58(Suppl. 1), (pp. 53-54). doi: 10.1177/00048674241241938

2023

Journal - Research Other

Eggleston, K., Douglas, K., Donovan, K., Tennant, M., & Mulder, R. (2023). Mental health and paid parental leave: What does the evidence say? New Zealand Medical Journal/Te ara tika o te hauora hapori, 136(1584), 7-9. Retrieved from https://journal.nzma.org.nz/

Douglas, K., Bell, C., Tanveer, S., Eggleston, K., Porter, R., & Boden, J. (2023). UNITE Project: uUnderstanding neurocognitive impairment after trauma exposure: Study protocol of an observational study in Christchurch, New Zealand. BMJ Open, 13, e072195. doi: 10.1136/bmjopen-2023-072195

Galbally, M., Eggleston, K., Northwood, K., Siskind, D., Berk, M., Suetani, S., … Every-Palmer, S. (2023). Renewal of academic psychiatry without addressing gender equity will render it Jurassic rather than endangered. Australian & New Zealand Journal of Psychiatry, 57(3), 315-321. doi: 10.1177/00048674221123494

2022

Journal - Research Article

Sukhapure, M., Eggleston, K., Fenton, A., Frampton, C., Porter, R. J., & Douglas, K. M. (2022). Changes in mood, anxiety, and cognition with polycystic ovary syndrome treatment: A longitudinal, naturalistic study. Neuropsychiatric Disease & Treatment, 18, 2703-2712. doi: 10.2147/NDT.S385014

Moot, W., Crowe, M., Inder, M., Eggleston, K., Frampton, C., & Porter, R. J. (2022). Domain-based functional improvements in bipolar disorder after interpersonal and social rhythm therapy. Frontiers in Psychiatry, 13, 767629. doi: 10.3389/fpsyt.2022.767629

Douglas, K. M., Groves, S., Crowe, M. T., Inder, M. L., Jordan, J., Carlyle, D., Wells, H., Beaglehole, B., Mulder, R., Lacey, C., Luty, S. E., Eggleston, K., Frampton, C. M. A., … Porter, R. J. (2022). A randomised controlled trial of psychotherapy and cognitive remediation to target cognition in mood disorders. Acta Psychiatrica Scandinavica, 145, 278-292. doi: 10.1111/acps.13387

Douglas, K. M., Fenton, A. J., Eggleston, K., & Porter, R. J. (2022). Rate of polycystic ovary syndrome in mental health disorders: A systematic review. Archives of Women's Mental Health, 25, 9-19. doi: 10.1007/s00737-021-01179-4

Sukhapure, M., Eggleston, K., Douglas, K., Fenton, A., Frampton, C., & Porter, R. J. (2022). Free testosterone is related to aspects of cognitive function in women with and without polycystic ovary syndrome. Archives of Women's Mental Health, 25, 87-94. doi: 10.1007/s00737-021-01158-9

Journal - Research Other

Douglas, K., Inder, M. L., Crowe, M. T., Jordan, J., Carlye, D., Lacey, C., Beaglehole, B., Mulder, R., Eggleston, K., Donovan, K. A., Frampton, C. M. A., … Porter, R. J. (2022). Randomised controlled trial of Interpersonal and Social Rhythm Therapy and group-based Cognitive Remediation versus Interpersonal and Social Rhythm Therapy alone for mood disorders: Study protocol. BMC Psychiatry, 22, 115. doi: 10.1186/s12888-022-03747-z

Eggleston, K., & Porter, R. (2022). Lymphadenopathy: A rare but important side effect of lamotrigine. Australian & New Zealand Journal of Psychiatry, 56(1), 99-100. doi: 10.1177/00048674211011260

2021

Journal - Research Article

Moot, W., Crowe, M., Inder, M., Eggleston, K., Frampton, C., & Porter, R. (2021). Functional and mood outcomes in bipolar disorder patients with and without substance use disorders undergoing psychotherapy. Frontiers in Psychiatry, 12, 661458. doi: 10.3389/fpsyt.2021.661458

Eggleston, M., Eggleston, K., Thabrew, H., Hennig, S., & Frampton, C. (2021). Order out of chaos? Autism spectrum disorder coordinators' impact on service delivery in New Zealand. Australasian Psychiatry, 29(6), 644-647. doi: 10.1177/10398562211009249

Crowe, M., Inder, M., Porter, R., Wells, H., Jordan, J., Lacey, C., Eggleston, K., & Douglas, K. (2021). Patients' perceptions of functional improvement in psychotherapy for mood disorders. American Journal of Psychotherapy, 74(1), 22-29. doi: 10.1176/appi.psychotherapy.202020200017

Journal - Research Other

Eggleston, K., & Porter, R. (2021). Cognitive screening in electroconvulsive therapy: Don't forget subjective cognition. Australian & New Zealand Journal of Psychiatry, 55(12), 1125-1126. doi: 10.1177/0004867421998784

Eggleston, K., & Myles, H. (2021). Advice to potential academics from researchers who have seen 'et al.'. Australian & New Zealand Journal of Psychiatry, 55(3), 235-238. doi: 10.1177/0004867420972757

Crowe, M., Eggleston, K., Douglas, K., & Porter, R. J. (2021). Effects of psychotherapy on comorbid bipolar disorder and substance use disorder: A systematic review. Bipolar Disorders, 23(2), 141-151. doi: 10.1111/bdi.12971

Conference Contribution - Published proceedings: Abstract

Porter, R., Moot, W., Crowe, M., Inder, M., Eggleston, K., & Frampton, C. (2021). Impact of co-morbid SUD on response to psychotherapy for bipolar disorder. Bipolar Disorders, 23(Suppl. 1), (pp. 33). doi: 10.1111/bdi.13101

Conference Contribution - Verbal presentation and other Conference outputs

Porter, R., Douglas, K., & Eggleston, K. (2021, September). Assessing understanding and treating cognitive difficulties in mental health conditions. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Scientific Conference, Queenstown, New Zealand.

2020

Journal - Research Other

Eggleston, K., & Porter, R. (2020). Subjective memory impairment after electroconvulsive therapy: Potentially modifiable? BJPsych Open, 6(3), e38. doi: 10.1192/bjo.2020.20

Crowe, M., Porter, R., Eggleston, K., & Douglas, K. (2020). Addressing cognitive impairment in mood disorders: A role for the mental health nurse. Journal of Psychiatric & Mental Health Nursing, 27, 319-320. doi: 10.1111/jpm.12613

Porter, R. J., & Eggleston, K. (2020). Neurocognitive effects of electroconvulsive therapy: What do patients and clinicians need to know? American Journal of Geriatric Psychiatry, 28(3), 317-319. doi: 10.1016/j.jagp.2019.10.017

Conference Contribution - Verbal presentation and other Conference outputs

Eggleston, K. (2020, November). Sex hormones and the brain: Testosterone is related to aspects of cognitive function in women. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: A Climate for Change: Nga Tohu Huarere e panoni haere nei, he ao hurihuri, Napier, New Zealand.

2019

Journal - Research Article

Eggleston, M. J. F., Thabrew, H., Frampton, C. M. A., Eggleston, K. H. F., & Hennig, S. C. (2019). Obtaining an autism spectrum disorder diagnosis and supports: New Zealand parents’ experiences. Research in Autism Spectrum Disorders, 62, 18-25. doi: 10.1016/j.rasd.2019.02.004

2018

Journal - Research Article

Reeves, S., Eggleston, K., Cort, E., McLachlan, E., Brownings, S., Nair, A., … Howard, R. (2018). Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP). International Journal of Geriatric Psychiatry, 33(2), 396-404. doi: 10.1002/gps.4758